市場調查報告書
商品編碼
1609945
美國氣管插管引入器市場規模、佔有率和趨勢分析報告:按最終用途、細分市場預測,2025-2030 年U.S. Tracheal Tube Introducers Market Size, Share & Trends Analysis Report By End Use (Hospitals And Clinics, Ambulatory Surgical Centers, Emergency Care Facilities/Urgent Care, Long-Term Facilities, Physician Offices) And Segment Forecasts, 2025 - 2030 |
Grand View Research, Inc.的最新報告顯示,2025年至2030年,美國氣管插管引進器市場預計將以4.82%的複合年成長率成長,到2030年將達到9,721萬美元。該市場受到多種因素的推動,包括國內企業的外科手術和戰略活動。因手術和緊急情況住院的人數不斷增加,已成為美國氣管插管插管器市場的關鍵機會。例如,根據2024年9月發表在《重症監護醫學》上的論文,美國醫療保險中的ICU入院人數為18,313,637人。如此高的住院人數增加了醫院和診所對高效呼吸道管理的需求。
此外,大量年輕人沉迷於吸煙和煙草習慣,這影響了呼吸道疾病的數量。根據 CDC 2024 年 9 月發布的資料,大約有 4,920 萬名居住在美國的成年人報告吸菸。此外,根據美國肺臟協會 2024 年 1 月發布的資料,到 2022 年,約 11.6% 的美國成年人吸菸。由於吸煙人口眾多,預計患有呼吸道疾病和慢性病的人數將會增加。呼吸系統疾病盛行率的增加預計將推動緊急情況下早期氣道干預的需求並推動市場成長。
此外,業內正在進行的研究預計將提供可靠的資訊並增加氣管插管導入器的採用。例如,根據麻醉醫師協會 2024 年 7 月發表的一篇論文,進行了一項研究來了解與氣管插管插管器相關的氣道損傷。這項研究得出的結論是,氣管導管導引器是安全的,可以降低氣道創傷的風險。此外,2024 年2 月發表在《急診醫學年鑑》上的一項研究發現,使用探條(氣管插管插管器)進行初始插管與提高急診科的插管成功率相關,這一點已明確。這項研究表明探條可能應該首先使用,而不是作為救援裝置。因此,此類研究預計將在未來幾年內支持美國氣管插管導入器市場的成長。
The U.S. tracheal tube introducers market is anticipated to reach USD 97.21 million by 2030, growing at a CAGR of 4.82% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by numerous factors such as surgical procedures and strategic activities by the players in the country. The increasing hospital admissions for surgeries and emergency conditions emerges as a significant opportunity in the U.S. tracheal tube introducers market. For instance, as per the article published in the journal "Critical Care Medicine" in September 2024, there were 18,313,637 ICU hospitalizations in Medicare in the U.S. This high number of hospitalizations increases the need for efficient airway management in hospitals and clinics.
Furthermore, a significant number of the young population is attracted to smoking and tobacco habits, which correspondingly impacts the number of respiratory diseases. According to the data published by the CDC in September 2024, around 49.2 million adults living in the U.S. reported tobacco use. Moreover, according to the data published by the American Lung Association in January 2024, around 11.6% of U.S. adults smoked cigarettes in 2022. Thus, an increasing number of individuals are anticipated to suffer from respiratory and chronic illnesses due to the presence of a large population having smoking habits. This increasing prevalence of respiratory illnesses is anticipated to boost the demand for early airway interventions in case of emergencies and thus propel the market growth.
Moreover, studies ongoing in the industry provide reliable information and are anticipated to increase the adoption of tracheal tube introducers. For instance, according to an article published by the Association of Anesthetics in July 2024, a study was performed to understand tracheal tube introducer-associated airway trauma. The study concluded that the tracheal tube introducers are safe and reduce the risk of airway trauma. Furthermore, the study published by the Annals of Emergency Medicine in February 2024 found that the bougie (an endotracheal tube introducer), as an asset in the first intubation attempt, was associated with improved success in emergency department intubations. This study suggests that bougie should probably be used first and not as a rescue device. Thus, such studies are anticipated to support U.S. tracheal tube introducers market growth in the coming years.